Dietary Supplement Importer and Distributor, 17 Years
Reference SI-025
Location Nationwide
Operating history 17 years
Status Operating
Revenue US$3.3M
Asking price US$8.2M
Stake offered 100%
Deal type Majority or full sale Overview Two-company structure: exclusive importer of US and Australian supplements plus a distributor covering all 63 provinces.
Key facts and assets Distribution to 100% of the large pharmacy chains 500k active customer records and an own TV-shopping channel Consolidated revenue US$3.29M a year; EBITDA US$615k; no bank debt Saves 7–10 years of import-licence building Who it suits Pharmaceutical groups and retail or healthcare funds.
Transaction sought Sale of 100% at an asking price of US$8.2M (about VND 200bn), negotiable.
USD figures are indicative, converted at about VND 25,500 per US$. Figures come from the seller and are unaudited.
Similar opportunities SI-024 Nationwide (HQ Ho Chi Minh City) Healthcare & Pharma
Closed-loop postnatal care brand: spa chain, herbal cosmetics workshop and its own training academy, expanding by franchise.
Revenue Not disclosed
Asking US$0.39M VND 10bn · for 30%
Stake 30%
SI-026 Mekong Delta (next to HCMC) Healthcare & Pharma
Twenty-seven-year-old pharmacy group with a 37% regional market share, over 90% cash sales and no debt.
Revenue US$2.7M VND 70bn
Asking US$1.8M
Stake 100%
SI-027 Thu Duc City, Ho Chi Minh City Healthcare & Pharma Project / greenfield
Greenfield smart-hospital project on titled healthcare land in an urban area of HCMC, designed to Japanese healthcare standards.
Revenue Not disclosed
Asking US$25M VND 650bn
Stake 100%
SI-001 Ho Chi Minh City Manufacturing & Packaging
Established PET packaging plant in an HCMC industrial park, running at about 70% of capacity, with B2B customers at home and in the US. The owner is relocating abroad and offers 100% of the business.
Revenue US$6.9M VND 175bn
Asking Not disclosed
Stake 100%
Buyers looking in this sector BM-02 Vietnam Private equity / venture fund Healthcare & Pharma
Domestic PE fund prioritising operating hospitals, with additional interest in retail, education, technology and logistics.
Min. revenue ≥ US$5M
Ticket US$5–20M
Stake 50–100%
BM-08 United States Private equity / venture fund Healthcare & Pharma
Long-established US investor taking minority equity of under 50% in health and life-sciences ventures.
Min. revenue —
Ticket US$0.5–5M
Stake Up to 49%
BM-15 International Strategic buyer Healthcare & Pharma
Acquirer expanding a healthcare system with an international orientation, preferring control or full ownership.
Min. revenue —
Ticket —
Stake 51–100%
